MedTech Acquisition Corporation
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Dec 18, 2020 |
| CEO | Christopher C. Dewey |
| Left Lead | Raymond James |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 6 + 3 |
| IPO Sector |
Healthcare
Healthcare in the United States |
| IPO Geography | US/Canada |
| Target Company | TriSalus Life Sciences |
| Deal Announced | Nov 14, 2022 |
| Deal Size, $M | $238.40M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Aug 8, 2023 |
| Amendment Vote | Jun 12, 2023 |
| Closing Date | Aug 10, 2023 |
Formerly MTAC
TLSI
TLSIW
| Price | $9.80 |
|---|---|
| Last closing price | $10.24 |
| H/L, 52-week | $4.11 / $16.24 |
| Volume, today | 282,885 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | $1.19 |
|---|---|
| Last closing price | $1.09 |
| High/low price, today | $1.08 / $1.19 |
| High/low price, 52-week | $0.09 / $0.48 |
| Volume, today | 800 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on MedTech Acquisition Corporation:
- Structure and cap table
- 9 directors & officers
- 53 filings and events
- 1 underwriters
- 2 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Karim Karti | 52 | Chairman |
| Christopher C. Dewey | 76 | CEO and Director |
| David J. Matlin | 59 | CFO and Director |
| Robert H. Weiss | 62 | CAO and Secretary |
| Martin Roche, MD | 54 | Director |
| Thierry Thaure | Director | |
| Manuel “Manny” Aguero | Director | |
| David L. Treadwell | Director | |
| Michael Stansky | Special Advisor |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Raymond James | BR | 22,000,000 | units |
| 22,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 53 filings.